Posts

Global Obesity – Epidemiology Insights and Forecast Report (Top 32 Markets) – 2020 To 2040

Global Obesity Epidemiology Insights Thelansis’s  “Global Obesity Epidemiology Insights and Forecast Report (Top 32 Markets) – 2020 To 2040 ″ provides an analysis of disease burden, characterized by disease definition, kidney biopsy cases, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America) . Obesity Overview Obesity is a complex, chronic disease characterized by excessive accumulation of body fat that impairs health and increases the risk of numerous comorbidities, including type 2 diabetes, cardiovascular dis...
Post a Comment
Read more

Global Obesity – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035

Global Obesity Market Outlook Thelansis’s  “Global Obesity Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035″  covers disease overview, epidemiology, kidney biopsy cases, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential IgA Nephropathy treatment modalities options for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Obesity Overview Obesity is a complex, chronic disease characterized by excessive accumulation of body fat that impairs health and increases the risk of numerous comorbidities, including type 2 diabetes, cardiovascular disease, certain cancers, and musculoskeletal disorders. It arises from an interplay of genetic, environmental, behavioral, and metabolic factors, with energy imbalance—calories consum...
Post a Comment
Read more

Global Alzheimer’s Disease – Epidemiology Insights and Forecast Report (Top 32 Markets) – 2020 To 2040

Global Alzheimer’s Disease Epidemiology Insights Thelansis’s  “Global Alzheimer’s Disease Epidemiology Insights and Forecast Report (Top 32 Markets) – 2020 To 2040 ″ provides an analysis of disease burden, characterized by disease definition, kidney biopsy cases, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America) . Alzheimer’s Disease Overview Alzheimer’s disease (AD) is the foremost cause of dementia, accounting for approximately 60% to 80% of all cases of dementia. This condition is a progressive and neurode...
Post a Comment
Read more

Global Alzheimer’s Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035

Global Alzheimer’s Disease Market Outlook Thelansis’s  “Global Alzheimer’s Disease Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035″  covers disease overview, epidemiology, kidney biopsy cases, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential IgA Nephropathy treatment modalities options for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Alzheimer’s Disease Overview Alzheimer’s disease (AD) is the foremost cause of dementia, accounting for approximately 60% to 80% of all cases of dementia. This condition is a progressive and neurodegenerative ailment characterized by three principal features within the brain: Amyloid plaques, anomalous clumps formed from proteins, remnants of neurons, and fragments of other ne...
Post a Comment
Read more

Global Rheumatoid Arthritis – Epidemiology Insights and Forecast Report (Top 32 Markets) – 2020 To 2040

Global Rheumatoid Arthritis Epidemiology Insights Thelansis’s  “Global Rheumatoid Arthritis Epidemiology Insights and Forecast Report (Top 32 Markets) – 2020 To 2040 ″ provides an analysis of disease burden, characterized by disease definition, kidney biopsy cases, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America) . Rheumatoid Arthritis Overview Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease characterized by persistent synovial inflammation that leads to joint pain, swelling, stiffness, a...
Post a Comment
Read more

Global Rheumatoid Arthritis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035

Global Rheumatoid Arthritis Market Outlook Thelansis’s  “Global Rheumatoid Arthritis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035″  covers disease overview, epidemiology, kidney biopsy cases, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential IgA Nephropathy treatment modalities options for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Rheumatoid Arthritis Overview Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease characterized by persistent synovial inflammation that leads to joint pain, swelling, stiffness, and progressive destruction of cartilage and bone. It most commonly affects small joints of the hands and feet in a symmetrical pattern, but can also involve larger joints and extra‑...
Post a Comment
Read more

Moderate to Severe Crohn’s Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Moderate to Severe Crohn’s Disease Market Outlook Thelansis’s “Moderate to Severe Crohn’s Disease Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Moderate to Severe Crohn’s Disease treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Moderate to Severe Crohn’s Disease Overview Moderate to severe Crohn’s disease is a chronic, relapsing inflammatory bowel disorder that can affect any part of the gastrointestinal tract, most commonly the terminal ileum and colon. Patients experience persistent abdominal pain, diarrhea, weight loss, fatigue, and in advanced cases, complications such as strictures, fistulas, and abscesses. The disease is...
Post a Comment
Read more